Here's why Pfizer (PFE) stock is surging

Pfizer (NYSE: PFE) shares rose nearly 3% to $25.98 in premarket trading on December 17 after the pharmaceutical giant released its 2025 financial guidance. While the outlook painted a mixed picture, investor sentiment leaned positive, driven by an optimistic earnings forecast that signals progress in Pfizer’s ongoing turnaround efforts.At press time, Pfizer stock was trading at $26.30, marking a 2.7% gain for the day, with the monthly chart showing a 3% increase. Despite these gains, Pfizer remains down 11% ...